Market Overview:
The global botulinum toxin market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Botulinum toxin is a neurotoxin produced by the bacterium Clostridium botulinum, which is an anaerobic, gram-positive, spore-forming rod commonly found in plants, soil, water, and intestinal tracts of animals. It plays a significant role in the management of a wide variety of medical conditions. These conditions include strabismus and focal dystonia, hemifacial spasm, headaches, hypersalivation, hyperhidrosis, and spastic movement disorders. Moreover, it is utilized in the treatment of various chronic diseases that respond partially to available medical treatments. Nowadays, it is also used for the cosmetic purpose of temporarily reducing frown lines, creases, and wrinkles on the face, chin, neck, and chest.
Botulinum Toxin Market Trends:
A significant rise in the prevalence and diagnosis of chronic and acute diseases represents one of the key factors bolstering the market growth. Botulinum toxin finds extensive applications in the treatment of dermatological conditions, such as overactive smooth muscles, abnormal activity of glands, and hyperhidrosis. Moreover, the rising beauty consciousness among individuals, along with their willingness to undergo reconstructive and cosmetic surgeries, is contributing to market growth. In addition, the emerging trend of cosmetic tourism, in confluence with the increasing influence of social media, rapid urbanization, and inflating per capita income, is influencing the market positively. Apart from this, as the skin becomes more susceptible to wrinkles and sagging with age, the growing geriatric population and the desire to retain young and healthy skin are bolstering the market growth. Furthermore, the development of new potent toxins by combining different serotypes can reduce the total units and overall antigenic dose and improve effectiveness and duration of effect. These advancements are projected to create a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global botulinum toxin market report, along with forecasts at the global, regional and country-level from 2021-2026. Our report has categorized the market based on type, application and end user.
Breakup by Type:
- Toxin Type A
- Toxin Type B
Breakup by Application:
Breakup by End User:
- Hospitals and Clinics
- Dermatology Clinics
- Spas and Cosmetic Centres
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Eisai Co. Ltd, Evolus Inc, Galderma SA, HUGEL Inc., Ipsen Group, Medytox Inc., Merz Pharma GmbH & Co. KGaA, Metabiologics Inc. and Revance Therapeutics Inc.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2020 |
| Historical Period |
2015-2020 |
| Forecast Period |
2021-2026 |
| Units |
US$ Billion |
| Segment Coverage |
Type, Application And End User, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
AbbVie Inc., Eisai Co. Ltd, Evolus Inc, Galderma SA, HUGEL Inc., Ipsen Group, Medytox Inc., Merz Pharma GmbH & Co. KGaA, Metabiologics Inc. and Revance Therapeutics Inc. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global botulinum toxin market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global botulinum toxin market?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global botulinum toxin market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Botulinum Toxin Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Toxin Type A
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Toxin Type B
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Application
7.1 Therapeutics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Aesthetics
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Dermatology Clinics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Spas and Cosmetic Centres
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 AbbVie Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Eisai Co. Ltd
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Evolus Inc
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.4 Galderma SA
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 SWOT Analysis
14.3.5 HUGEL Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6 Ipsen Group
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Medytox Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.8 Merz Pharma GmbH and Co. KGaA
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Metabiologics Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Revance Therapeutics Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
List of Figures
Figure 1: Global: Botulinum Toxin Market: Major Drivers and Challenges
Figure 2: Global: Botulinum Toxin Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Botulinum Toxin Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Botulinum Toxin Market: Breakup by Type (in %), 2020
Figure 5: Global: Botulinum Toxin Market: Breakup by Application (in %), 2020
Figure 6: Global: Botulinum Toxin Market: Breakup by End User (in %), 2020
Figure 7: Global: Botulinum Toxin Market: Breakup by Region (in %), 2020
Figure 8: Global: Botulinum Toxin (Toxin Type A) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Botulinum Toxin (Toxin Type A) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Botulinum Toxin (Toxin Type B) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Botulinum Toxin (Toxin Type B) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Botulinum Toxin (Therapeutics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Botulinum Toxin (Therapeutics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Botulinum Toxin (Aesthetics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Botulinum Toxin (Aesthetics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Botulinum Toxin (Hospitals and Clinics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Botulinum Toxin (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Botulinum Toxin (Dermatology Clinics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Botulinum Toxin (Dermatology Clinics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Botulinum Toxin (Spas and Cosmetic Centres) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Botulinum Toxin (Spas and Cosmetic Centres) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: North America: Botulinum Toxin Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: North America: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: United States: Botulinum Toxin Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: United States: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Canada: Botulinum Toxin Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Canada: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Asia-Pacific: Botulinum Toxin Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Asia-Pacific: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: China: Botulinum Toxin Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: China: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Japan: Botulinum Toxin Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Japan: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: India: Botulinum Toxin Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: India: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: South Korea: Botulinum Toxin Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: South Korea: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: Australia: Botulinum Toxin Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: Australia: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: Indonesia: Botulinum Toxin Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: Indonesia: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: Others: Botulinum Toxin Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: Others: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: Europe: Botulinum Toxin Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: Europe: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: Germany: Botulinum Toxin Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: Germany: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: France: Botulinum Toxin Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: France: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: United Kingdom: Botulinum Toxin Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: United Kingdom: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: Italy: Botulinum Toxin Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: Italy: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: Spain: Botulinum Toxin Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: Spain: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Russia: Botulinum Toxin Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Russia: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: Others: Botulinum Toxin Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: Others: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: Latin America: Botulinum Toxin Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: Latin America: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Brazil: Botulinum Toxin Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Brazil: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Mexico: Botulinum Toxin Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: Mexico: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Others: Botulinum Toxin Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Others: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Middle East and Africa: Botulinum Toxin Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Middle East and Africa: Botulinum Toxin Market: Breakup by Country (in %), 2020
Figure 70: Middle East and Africa: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: Global: Botulinum Toxin Industry: SWOT Analysis
Figure 72: Global: Botulinum Toxin Industry: Value Chain Analysis
Figure 73: Global: Botulinum Toxin Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Botulinum Toxin Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Botulinum Toxin Market Forecast: Breakup by Type (in Million US$), 2021-2026
Table 3: Global: Botulinum Toxin Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 4: Global: Botulinum Toxin Market Forecast: Breakup by End User (in Million US$), 2021-2026
Table 5: Global: Botulinum Toxin Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Botulinum Toxin Market: Competitive Structure
Table 7: Global: Botulinum Toxin Market: Key Players